News 

 

Scientists identify antibodies that can neutralize omicron

| January 6, 2022 | 0 comments
An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike protein that remain essentially unchanged as the viruses mutate. By identifying the targets of these “broadly neutralizing” antibodies on the spike protein, it might be possible to design vaccines and antibody treatments
iPharmaTrials, News, Press Releases
Stoned drivers are a lot safer than drunk ones, new federal data shows

Stoned drivers are a lot safer than drunk ones, new federal data shows

| June 21, 2019 | 0 comments
A new study from the National Highway Traffic Safety Administration finds that drivers who use marijuana are at a significantly lower risk for a crash than drivers who use alcohol. And after adjusting for age, gender, race and alcohol use, drivers who tested positive for marijuana were no more likely to crash than who had
driving, medical marijuana
iPharmaTrials, News, Press Releases
Breaking News! Cannabis and Psychosis: Triangulating the Evidence

Breaking News! Cannabis and Psychosis: Triangulating the Evidence

| May 7, 2019 | 0 comments
Disentangling causality where complex and confounded behaviours might be impacting on even more complex mental health outcomes is notoriously challenging, and requires tackling the question in a number of different ways to triangulate the evidence. Although observational epidemiology and experimental studies are broadly consistent in indicating a link between heavy cannabis use and risk of
iPharmaTrials, News
Driver in Limousine Crash had Marijuana in System

Driver in Limousine Crash had Marijuana in System

| April 7, 2019 | 0 comments
Traces of anti-seizure medicine also were found in post-mortem tests SCHOHARIE — The driver of a Ford Excursion limousine that crashed in Schoharie last October, killing 20 people, had a “significant” amount of marijuana in his system at the time he died, according to two people with knowledge of the driver’s post-mortem toxicology report. The
anti-seizure medicine
iPharmaTrials, News, Press Releases
Health Effects of Cannabis and Cannabinoids

Health Effects of Cannabis and Cannabinoids

| January 14, 2019 | 0 comments
In the report The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research, an expert, ad hoc committee of the National Academies of Sciences, Engineering, and Medicine presents nearly 100 conclusions related to the health effects of cannabis and cannabinoid use. The committee developed standard language to categorize the
Cannabinoids, Cannabis
iPharmaTrials, News, Press Releases

*BREAKING NEWS* Image-Guided Surgery

| April 7, 2018 | 0 comments
What is image-guided surgery? The focus of On Target Laboratories is the discovery and development of small molecules that, when conjugated with fluorescent dyes, target and illuminate specific cancerous cells and other diseased tissue. This illumination may provide the surgeon with a clearer view of diseased tissue, creating another decision-making tool to benefit the patient.
iPharmaTrials, News, Press Releases

Cardiac Diffusion Tensor Imaging Parameters and Anthropometrics

| April 5, 2018 | 0 comments
Relationship between Cardiac Diffusion Tensor Imaging Parameters and Anthropometrics in Healthy Volunteers Background In vivo cardiac diffusion tensor imaging (cDTI) is uniquely capable of interrogating laminar myocardial dynamics non-invasively. A comprehensive dataset of quantative parameters and comparison with subject anthropometrics is required. Methods cDTI was performed at 3T with a diffusion weighted STEAM sequence. Data
iPharmaTrials, News, Press Releases
First Blood Test to Help Diagnose Brain Injuries gets US Okay

First Blood Test to Help Diagnose Brain Injuries gets US Okay

| February 21, 2018 | 0 comments
by Lindsey Tanner, AP Medical Writer CHICAGO — Feb 14, 2018, 9:04 PM ET The first blood test to help doctors diagnose traumatic brain injuries has won U.S. government approval. The move means Banyan Biomarkers can commercialize its test, giving the company an early lead in the biotech industry’s race to find a way to diagnose
Brain Trauma Indicator, TBI
iPharmaTrials, News, Press Releases
Cannabinoid May Be First Drug for Sleep Apnea

Cannabinoid May Be First Drug for Sleep Apnea

| January 28, 2018 | 0 comments
By Nancy A. Melville / Medscape – Jan 25, 2018 Dronabinol, a synthetic form of the cannabis compound tetrahydrocannabinol (THC), shows efficacy in the treatment of obstructive sleep apnea, possibly representing a first pharmacologic approach to the tough-to-treat, but potentially serious, condition. “These findings support the therapeutic potential of cannabinoids in patients with obstructive sleep
Cannabinoid, Sleep Apnea
iPharmaTrials, News, Press Releases
OVERVIEW OF RESTLESS LEGS SYNDROME

OVERVIEW OF RESTLESS LEGS SYNDROME

| November 3, 2017 | 0 comments
Characterized by an uncomfortable and irresistible urge to move the legs, restless legs syndrome is a sensorimotor disorder involving the nervous system. Restless legs syndrome, also called commonly referred to as RLS or Willis-Ekbom disease, typically worsens when lying or sitting. As a result, the syndrome is commonly accompanied with sleep problems, exhaustion, daytime sleepiness,
Cannabis, cannabis inhalation, cannabis treatments, Restless legs syndrome, RLS, Willis-Ekbom disease
iPharmaTrials, News, Press Releases

Resources

 

– Krishna’s Corner
– Krishna’s Blog
– Store

iPT Tweets

 

News

 

iPHARMA TRIALS

 

New York, USA
Telephone : 718-332-7878
rkrishna -AT- ipharmatrials.com
.. replace -AT- with @

United Kingdom
The Studio/East Batterlaw Farm
Seaham SR7 8RP

Corporation Registration Address:
330 Thornton Road Englewood NJ 07631